Evgen PLC - Clinical Trial Update

20th February 2019

CEO Steve Franklin expects transformative year for the company.

Evgen Pharma plc is pleased to announce updates on its clinical trial programme. The last patient has now completed the STEM Phase IIa trial, the Company continues to expect the final data read-out in the latter part of Q1 2019.

Also, the last patient has been recruited to SAS Phase II trial. The Company anticipates, in-line with market expectation, the read-out of the primary endpoints of the trial in Q2 calendar year 2019.

To know more click here.